ASTRAZENECA PLC (AZN)
Clinical trial NCT06834932 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2027-02-22 → 2025-07-03 3. enrollment: 360 → 432 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06834932 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2027-02-22 → 2025-07-03 3. enrollment: 360 → 432 participants 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical